Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer
Clinical trial NCT06093438 · RECRUITING
Trial details
- NCT number
- NCT06093438
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.